<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sleep-wake disorders in patients with traumatic brain injury</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sleep-wake disorders in patients with traumatic brain injury</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Sleep-wake disorders in patients with traumatic brain injury</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Miranda M Lim, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Christian R Baumann, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas E Scammell, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">April F Eichler, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 05, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H4070056305"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Sleep-wake disturbances are among the most prevalent and persistent sequelae of traumatic brain injury (TBI) [<a href="#rid1">1-3</a>]. Patients suffering from TBI of any severity, in both the acute and chronic phases, commonly report excessive daytime sleepiness, increased sleep need, insomnia, and sleep fragmentation [<a href="#rid4">4-6</a>].</p><p>Identification and treatment of sleep disorders in patients with TBI is important and can complement other efforts to promote maximum functional recovery.</p><p>The clinical features, evaluation, and treatment of sleep-wake disorders in patients with TBI are discussed here. The classification of TBI and management of other complications of head injury, including the postconcussion syndrome, are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/4825.html" rel="external">"Traumatic brain injury: Epidemiology, classification, and pathophysiology"</a> and  <a class="medical medical_review" href="/z/d/html/4828.html" rel="external">"Acute mild traumatic brain injury (concussion) in adults"</a> and  <a class="medical medical_review" href="/z/d/html/4830.html" rel="external">"Postconcussion syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/111925.html" rel="external">"Sequelae of mild traumatic brain injury"</a>.)</p><p class="headingAnchor" id="H1195502"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>TBI is a well-established risk factor for incident sleep disorders. In a cohort study of nearly 100,000 United States military veterans who sustained TBI and the same number of age-matched veterans without TBI, those with TBI were 41 percent more likely to develop a new sleep-wake disturbance over a mean follow-up of five years, after adjustment for multiple demographic variables and medical conditions [<a href="#rid7">7</a>].</p><p>The point prevalence of sleep-wake disturbances after TBI varies depending on the phase and severity of injury. TBI severity is most commonly classified according to the Glasgow Coma Scale (GCS)  (<a class="graphic graphic_table graphicRef81854" href="/z/d/graphic/81854.html" rel="external">table 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mild TBI </strong>– Sleep-wake complaints are reported by approximately one-third of adults within the first 10 days after mild TBI and up to 50 percent at six weeks post-injury [<a href="#rid8">8-11</a>]. Risk factors for persistent sleep disturbance may include female sex, poor pre-injury sleep quality, and symptoms of poor sleep or cognition within two weeks after injury [<a href="#rid11">11</a>]. A meta-analysis of 44 observational studies of sleep disturbances in children after mild TBI found a pooled prevalence of 51 percent within one week and 21 percent after three months [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Severe TBI</strong> – The prevalence is even higher among individuals with severe TBI [<a href="#rid13">13,14</a>]. In a prospective study of 205 patients admitted to an acute rehabilitation hospital after severe TBI, 84 percent had sleep-wake disturbances upon admission, and 66 percent continued to have disturbances at one month post-injury [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic phase </strong>–<strong> </strong>In observational studies of survivors of TBI, the most common sleep disturbances reported in the chronic phase (&gt;3 months after injury) are [<a href="#rid15">15</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Insomnia (50 percent)</p><p class="bulletIndent2"><span class="glyph">•</span>Difficulty maintaining sleep (50 percent)</p><p class="bulletIndent2"><span class="glyph">•</span>Poor sleep efficiency on polysomnography (PSG) (49 percent)</p><p class="bulletIndent2"><span class="glyph">•</span>Early morning awakenings (38 percent)</p><p class="bulletIndent2"><span class="glyph">•</span>Nightmares (27 percent)</p><p></p><p class="bulletIndent1">Of note, many studies evaluate the subjective experience of insomnia without objective sleep measurement using electrophysiologic testing [<a href="#rid15">15</a>]. This is relevant given that, in at least one study, brain-injured patients tended to overestimate insomnia when subjective and objective measures were compared [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1">Additional abnormalities on formal testing in survivors of TBI include excessive daytime sleepiness, increased sleep need, and sleep-related breathing disorders [<a href="#rid5">5,15,17,18</a>]. </p><p></p><p class="headingAnchor" id="H1195508"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>The pathophysiology and neuropathology of sleep-wake disturbances after TBI are under investigation in both animal models and humans [<a href="#rid3">3</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Orexin (hypocretin) and the hypothalamus </strong>– Changes in the neuropeptide orexin (also known as hypocretin), which is deficient in human narcolepsy type 1, likely play a role in sleepiness and sleep fragmentation after TBI. Orexin neurons in the posterior hypothalamus excite several downstream wake-promoting monoaminergic and cholinergic systems and therefore possess a strong wake-promoting effect [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1">Studies in patients have identified low orexin levels in the cerebrospinal fluid (CSF) within the first four days of moderate to severe TBI as well as a reduction in the number of orexin neurons in the hypothalamus in autopsy specimens [<a href="#rid20">20,21</a>]. Mouse models of mild and moderate TBI show decreased brain orexin levels and decreased orexin neuron activation during wakefulness after brain injury [<a href="#rid22">22-24</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other wake-promoting brain regions</strong> – Other wake-promoting areas of the brain, such as the ventral periaqueductal gray, locus coeruleus, basal forebrain, and tuberomammillary nucleus, could also play a role. Postmortem studies in patients with severe TBI have shown loss of histaminergic neurons in the tuberomammillary nucleus [<a href="#rid25">25</a>], loss of serotonergic dorsal raphe nuclei neurons, and loss of noradrenergic locus coeruleus neurons [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Melatonin</strong> – Melatonin is produced by the pineal gland and regulates the sleep-wake cycle following a circadian pattern of release into the bloodstream. Several studies in TBI survivors have shown alterations in melatonin secretion compared with controls in both the acute and chronic phases after injury [<a href="#rid27">27-30</a>]. Despite this data, however, exogenous melatonin does not appear to be helpful after TBI. (See <a class="local">'Insomnia'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Structural brain changes</strong> – Abnormal neuroimaging is found in only a minority of patients with mild TBI, although imaging is likely to miss more subtle brain damage such as diffuse axonal injury or microhemorrhages, which may affect sleep-wake and circadian circuits. In an electrophysiologic and imaging study, intracranial hemorrhage due to TBI was associated with increased sleep need, independent of the extent and location of the hemorrhage [<a href="#rid31">31</a>]. In a separate study, analysis of microbleed patterns in patients with coma due to severe TBI found a variety of affected arousal nuclei, rather than a single nucleus affected in all patients [<a href="#rid32">32</a>].</p><p></p><p class="headingAnchor" id="H1195514"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H962417"><span class="h2">Symptom spectrum</span><span class="headingEndMark"> — </span>The most common manifestations of sleep-wake disorders after TBI are excessive daytime sleepiness, increased sleep need, and insomnia [<a href="#rid7">7</a>]. Less commonly, patients experience circadian sleep-wake rhythm disturbances and abnormal movements or behaviors during sleep, such as sleep talking, bruxism, and dream enactment.</p><p class="headingAnchor" id="H1195520"><span class="h3">Excessive daytime sleepiness</span><span class="headingEndMark"> — </span>Excessive daytime sleepiness, distinct from fatigue, is a prominent symptom after TBI. The reported frequency in patients with TBI ranges from approximately 50 to 80 percent, compared with an expected rate in the general population of 10 to 25 percent [<a href="#rid33">33-36</a>].</p><p>Excessive daytime sleepiness refers to the inability to maintain wakefulness and alertness during the major waking episodes of the day, with sleep occurring unintentionally or at inappropriate times [<a href="#rid37">37</a>]. Sleepiness manifests mainly during sedentary activities, in contrast with fatigue, which typically affects pursuit of more active goals. (See  <a class="medical medical_review" href="/z/d/html/14892.html" rel="external">"Approach to the patient with excessive daytime sleepiness", section on 'Definitions'</a>.)</p><p>Some individuals with excessive daytime sleepiness after TBI describe daytime sleep attacks, similar to those experienced by patients with narcolepsy. However, additional symptoms of narcolepsy, such as cataplexy and sleep paralysis, are uncommon and have been described only in rare case reports [<a href="#rid38">38</a>]. No patient has been reported with the complete syndrome of posttraumatic orexin-deficient narcolepsy with cataplexy.</p><p>Subjective excessive daytime sleepiness is often but not always accompanied by a short time to fall asleep on the multiple sleep latency test (MSLT). A mean sleep latency of ≤8 minutes is generally considered to be abnormal. In addition to a reduced mean sleep latency, some patients have two or more sleep-onset rapid eye movement (REM) periods (SOREMPs) during the MSLT, fulfilling electrophysiologic criteria for narcolepsy type 2 (narcolepsy without cataplexy). However, before diagnosing narcolepsy after TBI, insufficient sleep syndrome must be ruled out, as chronic sleep deprivation can produce increased REM sleep pressure. (See  <a class="medical medical_review" href="/z/d/html/7689.html" rel="external">"Clinical features and diagnosis of narcolepsy in adults", section on 'Diagnosis'</a>.)</p><p>In one prospective study of 65 patients six months after TBI, 28 percent had posttraumatic sleepiness and 3 percent met criteria for narcolepsy type 2 [<a href="#rid17">17</a>]. A similar study found that 6 percent of patients met MSLT criteria for narcolepsy type 2 at a mean of 64 months after TBI, a marked increase compared with the prevalence in the general population (&lt;0.1 percent) [<a href="#rid5">5,39</a>]. Other studies have also found that sleepiness persists long term in many patients [<a href="#rid40">40</a>]. (See <a class="local">'Natural history'</a> below.)</p><p>Kleine-Levin syndrome, a recurrent and severe hypersomnia, may occur in response to precipitating events such as TBI. In one large series of 186 patients with Kleine-Levin syndrome, 9 percent reported symptoms starting shortly after TBI [<a href="#rid41">41</a>]. (See  <a class="medical medical_review" href="/z/d/html/14897.html" rel="external">"Kleine-Levin syndrome (recurrent hypersomnia)"</a>.)</p><p class="headingAnchor" id="H1195526"><span class="h3">Increased sleep need (pleiosomnia)</span><span class="headingEndMark"> — </span>Increased sleep need is common after TBI. Since the term hypersomnia is often used for both excessive daytime sleepiness and increased sleep need, the term pleiosomnia has been proposed to denote an increased need for sleep per 24 hours compared with the patient's pre-TBI baseline [<a href="#rid42">42</a>].</p><p>In a prospective electrophysiologic study of 65 patients who were studied six months after TBI, 22 percent reported that they needed at least two more hours of sleep in a 24-hour period than before the injury [<a href="#rid17">17</a>]. This general pattern was confirmed in a prospective case control study that included 42 patients with TBI studied six months after injury, in which post-TBI patients slept 1.2 hours more than matched controls [<a href="#rid31">31</a>]. This pattern persisted at 18 months [<a href="#rid40">40</a>]. (See <a class="local">'Natural history'</a> below.)</p><p>In both of these studies, patients with TBI underestimated both excessive daytime sleepiness and pleiosomnia [<a href="#rid17">17,31</a>]. In addition, daytime sleepiness was more pronounced in TBI patients with shorter sleep duration, suggesting that sleepiness might constitute an epiphenomenon of insufficient sleep in subjects needing more sleep than usual.</p><p class="headingAnchor" id="H1195532"><span class="h3">Insomnia</span><span class="headingEndMark"> — </span>Insomnia has been widely documented in the chronic phases after TBI. Symptoms may include difficulty initiating sleep, sleep fragmentation, and early morning awakenings, plus negative consequences on daytime performance, vigilance, and mood.</p><p>Insomnia tends to be more prevalent after mild TBI compared with moderate or severe TBI [<a href="#rid43">43,44</a>], affecting more than 70 percent of patients [<a href="#rid45">45</a>]. Repeated head injuries may also be a risk factor [<a href="#rid46">46</a>]. The 12-month course of insomnia after TBI is markedly heterogeneous; some patients have acute mild to severe insomnia that remits, some have stable/persistent insomnia, and others have delayed onset of insomnia [<a href="#rid47">47</a>].</p><p>Insomnia often persists long term in TBI survivors. In one study, insomnia was present in approximately one-quarter of patients five years after injury [<a href="#rid43">43</a>]. In studies of military service members with TBI, rates of insomnia are greater than 50 percent at 15 to 20 years after injury [<a href="#rid48">48,49</a>].</p><p>The presence of insomnia correlates with decreased satisfaction in life, anxiety, and depression [<a href="#rid50">50</a>]. (See  <a class="medical medical_review" href="/z/d/html/7684.html" rel="external">"Risk factors, comorbidities, and consequences of insomnia in adults"</a>.)</p><p class="headingAnchor" id="H1195550"><span class="h3">Circadian sleep-wake rhythm disturbances</span><span class="headingEndMark"> — </span>There is preliminary evidence that disorders of sleep-wake timing (circadian rhythm sleep-wake disorders), including delayed sleep-wake phase disorder, irregular sleep-wake rhythm disorder, and non-24-hour sleep-wake rhythm disorder, occur with increased frequency in patients with TBI.</p><p>In moderate to severe TBI, actigraphy recordings in 16 patients within the first 10 days post-injury revealed severe fragmentation of the rest-activity cycle, reflecting severe sleep-wake fragmentation and possibly consistent with an irregular sleep-wake rhythm disorder [<a href="#rid51">51</a>]. </p><p>Symptoms of a circadian sleep-wake rhythm disorder are easy to overlook and are often misattributed to insomnia [<a href="#rid52">52-54</a>]. An assessment of circadian sleep-wake rhythm dysfunction is therefore particularly relevant in patients with a history of TBI who present with chronic insomnia symptoms [<a href="#rid54">54</a>]. The distinction is important, since treatment approaches differ. (See  <a class="medical medical_review" href="/z/d/html/7676.html" rel="external">"Evaluation and diagnosis of insomnia in adults", section on 'Differential diagnosis'</a>.)</p><p>Patients with delayed sleep-wake phase syndrome typically go to bed late and wake up late relative to the general population. They may complain of difficulty falling asleep at usual bed times, and difficulty getting up at standard wake times. This may be confused with insomnia, in which patients have difficulty falling asleep or staying asleep regardless of bed time. (See  <a class="medical medical_review" href="/z/d/html/97845.html" rel="external">"Delayed sleep-wake phase disorder", section on 'Clinical features'</a>.) </p><p>Patients with an irregular sleep-wake rhythm lack a clearly defined circadian rhythm of sleep and wakefulness, such that sleep and wake patterns appear somewhat random across days to weeks. They may complain of both difficulty sleeping at the desired time and excessive daytime sleepiness and naps. Although insomnia can be accompanied by complaints of excessive daytime sleepiness, it is more commonly associated with difficulty napping or sleeping during the day. (See  <a class="medical medical_review" href="/z/d/html/97844.html" rel="external">"Overview of circadian rhythm sleep-wake disorders"</a>.)</p><p class="headingAnchor" id="H1195556"><span class="h3">Abnormal movements or behaviors during sleep</span><span class="headingEndMark"> — </span>Parasomnias and sleep-related movement disorders may occur with increased frequency after TBI in both the acute and chronic phases.</p><p>Symptoms include dream reenactment behaviors characteristic of REM sleep behavior disorder (RBD), somniloquy (sleep talking), sleep-related enuresis, and sleep-related bruxism (teeth grinding) [<a href="#rid55">55-57</a>].</p><p>Posttraumatic stress disorder (PTSD) increases the risk of RBD beyond what is seen with TBI alone [<a href="#rid57">57</a>]. A parasomnia distinct from RBD, "trauma-associated sleep disorder," has been postulated, which encompasses the clinical triad of dream enactment, REM sleep without atonia (RSWA), and autonomic hyperarousal (eg, tachycardia). This parasomnia was first noted in military personnel, and TBI as a triggering event is thought to be a risk factor [<a href="#rid58">58-60</a>]. </p><p>Of note, it is not yet clear whether trauma-associated sleep disorder and/or RBD after TBI are associated with future risk of neurodegenerative synucleinopathy, as is the case in idiopathic RBD [<a href="#rid61">61,62</a>]. Since TBI and PTSD are risk factors for Parkinson disease, the association of RBD with TBI/PTSD could reflect an early clinical manifestation of posttraumatic neurodegeneration [<a href="#rid63">63</a>]. (See  <a class="medical medical_review" href="/z/d/html/14894.html" rel="external">"Rapid eye movement sleep behavior disorder", section on 'Etiology'</a>.)</p><p class="headingAnchor" id="H961039"><span class="h3">Sleep-disordered breathing</span><span class="headingEndMark"> — </span>Sleep-related breathing disorders, including obstructive sleep apnea (OSA) and central sleep apnea (CSA), may occur with increased frequency after TBI [<a href="#rid5">5,64,65</a>]. The reported prevalence of OSA varies widely across studies, ranging from 11 to 77 percent [<a href="#rid15">15,17,66,67</a>]. The highest rates have been in studies that enrolled military personnel with sleep complaints from a sleep clinic, a population known to be enriched for sleep problems [<a href="#rid33">33,66,68</a>].</p><p>Many symptoms of OSA overlap with those of TBI as well as other sleep-wake disorders. The most common symptoms of OSA in the general population are daytime sleepiness and loud snoring. Additional symptoms include waking up gasping or choking, morning headaches, nocturia, moodiness or irritability, lack of concentration, and memory impairment. On physical examination, patients are often obese and may have evidence of a crowded oropharynx and increased neck circumference. Clinical features of CSA are similar, except that obesity is less likely to be present. (See  <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults", section on 'Clinical features'</a>.)</p><p class="headingAnchor" id="H1195562"><span class="h2">Important comorbidities</span><span class="headingEndMark"> — </span>Psychiatric disorders and chronic pain commonly co-occur in patients with TBI. These comorbidities are important to recognize, since they may cause or exacerbate a wide range of sleep-wake disturbances.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Depression and anxiety</strong> – Patients with TBI have high rates of depression and anxiety. In some, depression and anxiety are premorbid conditions that may be exacerbated after TBI; in others, depression or anxiety emerges after TBI [<a href="#rid69">69,70</a>].</p><p></p><p class="bulletIndent1">Nearly 75 percent of adults with depression report sleep difficulties, including insomnia, excessive daytime sleepiness, increased sleep need, early morning awakenings, and sleep fragmentation [<a href="#rid71">71</a>]. TBI may exacerbate sleep-wake disturbances in patients with comorbid depression and anxiety [<a href="#rid72">72,73</a>]. Conversely, untreated depression or anxiety may prevent successful treatment of sleep disturbances in patients with TBI.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Posttraumatic stress disorder</strong> – TBI and PTSD commonly co-occur, especially in the military population, rendering a much higher incidence of PTSD-related nightmare disorder and dream enactment compared with the non-TBI population [<a href="#rid74">74,75</a>]. TBI may increase vulnerability to PTSD by damaging autonomic networks in the central nervous system [<a href="#rid76">76</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic pain</strong> – Patients with TBI report more difficulty managing pain [<a href="#rid77">77</a>]. In a systematic review of 23 studies and over 4000 patients with TBI, chronic pain affected 52 percent of patients [<a href="#rid78">78</a>]. Chronic pain affects sleep quality by fragmenting sleep and reducing slow-wave sleep [<a href="#rid79">79</a>].</p><p></p><p class="headingAnchor" id="H962503"><span class="h2">Electrophysiologic changes</span><span class="headingEndMark"> — </span>Electrophysiologic changes in sleep are apparent in both the acute and chronic stages of TBI and vary according to the severity of the injury.</p><p>In the acute stage after mild TBI, patients may show longer sleep latency and lower sleep efficiency, along with lower delta power (but higher alpha and beta power) during non-REM (NREM) sleep [<a href="#rid80">80,81</a>]. This electroencephalogram (EEG) pattern of fast frequencies intruding into deep NREM sleep has been described in insomnia patients and may represent a deficit in turning off arousal [<a href="#rid82">82</a>].</p><p>EEG patterns in the acute stage after severe TBI may have prognostic implications. Slow-wave sleep, sleep spindle density, and other markers of sleep quality on EEG in the acute phase have been associated with improved modified Rankin Scale scores, rates of discharge to home or acute rehabilitation after hospitalization, and long-term cognitive outcomes [<a href="#rid83">83,84</a>]. Conversely, poor sleep after TBI has been associated with impeded recovery [<a href="#rid85">85</a>].</p><p>Chronic changes in sleep architecture have also been described after TBI across of range of severities. In a meta-analysis of 14 observational studies, chronic TBI (&gt;6 months after injury) was associated with increased slow wave sleep (SWS), and moderate to severe TBI was associated with reduced stage 2 sleep and reduced sleep efficiency [<a href="#rid86">86</a>].</p><p class="headingAnchor" id="H3720690536"><span class="h2">Natural history</span><span class="headingEndMark"> — </span>Many of the sleep-wake disturbances described above appear to persist long term after TBI and have a chronic impact on well-being [<a href="#rid87">87</a>]. This was illustrated by a prospective case-control study in which 31 out of 60 patients with TBI of any severity were evaluated at 18 months after injury [<a href="#rid40">40</a>]. Key findings included the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Pleiosomnia persisted at 18 months, independent of the severity of TBI and other clinical characteristics. Compared with healthy controls, patients with TBI required significantly more sleep per 24 hours at both six months (8.3 versus 7.1 hours) [<a href="#rid31">31</a>] and 18 months after injury (8.1 versus 7.1 hours) [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Two-thirds of patients with TBI had objective evidence of excessive daytime sleepiness on MSLT at 18 months, and symptoms were largely unrecognized by patients.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>As in the earlier phases of injury, patients underestimated their degree of sleepiness and sleep need on sleep logs and questionnaires.</p><p></p><p class="headingAnchor" id="H1195586"><span class="h1">EVALUATION</span><span class="headingEndMark"> — </span>Sleep-wake disorders are common after TBI and should be suspected in patients presenting with a broad range of sleep complaints. The goals of the evaluation are to define the sleep complaint, diagnose specific treatable sleep disorders, and identify any additional medical and psychiatric comorbidities that may be contributing to the sleep disturbances.</p><p>Most sleep-wake disorders are diagnosed using a combination of both subjective and objective screening tools in the clinic [<a href="#rid88">88</a>]. Subjective tools include a sleep history and questionnaires completed by patients, while objective tools include actigraphy, polysomnography (PSG), multiple sleep latency test (MSLT), and the maintenance of wakefulness test (MWT).</p><p>Patients with TBI may overestimate insomnia complaints, whereas they underestimate excessive daytime sleepiness and sleep need [<a href="#rid16">16,31,34,40,89,90</a>]. These observations stress the importance of objective sleep testing in patients with TBI.</p><p class="headingAnchor" id="H4070056861"><span class="h2">History</span><span class="headingEndMark"> — </span>The goals of the history are to refine the sleep complaint and identify potential causes.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assess multiple domains</strong> – Questions should target multiple sleep domains, including perceived sleep quality, sleep latency, sleep duration, sleep disturbances (including abnormal movements or behaviors during sleep), sleep medication use, daytime dysfunction, and daytime sleepiness. The Pittsburgh Sleep Quality Index (PSQI)  (<a class="graphic graphic_table graphicRef106689" href="/z/d/graphic/106689.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef107236" href="/z/d/graphic/107236.html" rel="external">table 3</a>) is a clinical questionnaire encompassing multiple sleep domains that can be useful to guide a structured interview [<a href="#rid91">91</a>] and has been partially validated in the TBI population [<a href="#rid34">34,92,93</a>]. In TBI populations, a more stringent cutoff score (eg, ≥8 instead of &gt;5) may improve PSQI validity [<a href="#rid92">92,94</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Quantify sleepiness</strong> – For patients who complain predominantly of excessive daytime sleepiness, the history should attempt to differentiate sleepiness from other common complaints such as fatigue, lack of energy, or weakness. The Epworth Sleepiness Scale (ESS) (<a class="calc calc_professional" href="/z/d/html/13440.html" rel="external">calculator 1</a>) is a widely used instrument for quantifying subjective sleepiness that has also been partially validated in patients with TBI [<a href="#rid34">34,92,93</a>]. Scores of 10 or more points are generally considered abnormal and support the complaint of excessive daytime sleepiness. As with other measures, ESS scores should be used in combination with other tools, as patients with TBI may underestimate their degree of daytime impairment [<a href="#rid34">34</a>]. (See  <a class="medical medical_review" href="/z/d/html/7688.html" rel="external">"Quantifying sleepiness", section on 'Epworth Sleepiness Scale (ESS)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Review sleep diaries</strong> – In patients whose predominant complaint is insomnia, the history should elicit a detailed description of sleep habits over a 24-hour period and trends over time. This includes questions about sleep quantity and quality, sleep timing and regularity, quality of the sleep environment, and daytime symptoms. A sleep diary or log, to be completed by the patient in advance or following the initial evaluation, can be particularly helpful to supplement the history  (<a class="graphic graphic_table graphicRef87134" href="/z/d/graphic/87134.html" rel="external">table 4</a> and <a class="graphic graphic_table graphicRef87859" href="/z/d/graphic/87859.html" rel="external">table 5</a>).</p><p></p><p class="bulletIndent1">Sleep diaries have the advantage of assessing sleep quality, sleep quantity, and circadian patterns over many days or weeks. Review of a sleep diary can provide clues to circadian sleep-wake rhythm disturbances, which are often mistaken for insomnia (see <a class="local">'Circadian sleep-wake rhythm disturbances'</a> above). To more objectively assess circadian sleep-wake rhythm disorders, actigraphy recordings for two to three weeks are very useful. (See <a class="local">'Actigraphy'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obtain collateral history</strong> – Collateral information from family members and bed partners should be obtained if possible. In particular, bed partners are a more reliable source than the patient for information about snoring, periodic limb movements, acting out of dreams, sleep walking, and other parasomnias. Loud or habitual snoring and witnessed apneas can suggest a diagnosis of obstructive apnea and should prompt PSG, especially if the presenting complaint is daytime sleepiness. (See <a class="local">'Polysomnography'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Screen for psychiatric comorbidities</strong> – Given the frequent comorbidity of psychiatric disorders in patients with TBI and their implications for treatment, the history should also probe for symptoms of depression, anxiety, and posttraumatic stress disorder (PTSD). Patients can be screened for depression by asking about depressed mood, loss of interest or pleasure in activities, change in appetite or weight, psychomotor retardation or agitation, low energy, poor concentration, thoughts of worthlessness or guilt, and recurrent thoughts of death or suicide. A two- or nine-item screening tool such as the Patient Health Questionnaire (PHQ)-9 or its abbreviated form is easy to use, reliable, and valid in primary care settings  (<a class="graphic graphic_table graphicRef59307" href="/z/d/graphic/59307.html" rel="external">table 6</a>). (See  <a class="medical medical_review" href="/z/d/html/83887.html" rel="external">"Screening for depression in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Review medications and substances</strong> – The medication list should be reviewed in all patients to identify potentially contributing agents. A wide variety of medications used in the management of acute complications of TBI may contribute to daytime sleepiness, including antiepileptic drugs, opioid analgesics, benzodiazepines, antipsychotics, and certain antidepressants  (<a class="graphic graphic_table graphicRef86811" href="/z/d/graphic/86811.html" rel="external">table 7</a>). The list is similarly long for drugs that may cause or aggravate insomnia (eg, glucocorticoids, bronchodilators, and central nervous system stimulants)  (<a class="graphic graphic_table graphicRef50646" href="/z/d/graphic/50646.html" rel="external">table 8</a>). Opioids, alcohol use, and substance abuse are also relevant for sleep disturbances including sleep-related breathing disorders. (See  <a class="medical medical_review" href="/z/d/html/97859.html" rel="external">"Sleep-disordered breathing in patients chronically using opioids"</a>.)</p><p></p><p class="headingAnchor" id="H964540"><span class="h2">Laboratories</span><span class="headingEndMark"> — </span>Basic laboratories are likely to be of low yield in the evaluation of sleep-wake disorders. Serum thyroid stimulating hormone (TSH) and ferritin may be useful in ruling out sleep-wake disturbances secondary to thyroid disorders and iron insufficiency. (See  <a class="medical medical_review" href="/z/d/html/4892.html" rel="external">"Clinical features and diagnosis of restless legs syndrome and periodic limb movement disorder in adults", section on 'Low iron stores'</a>.)</p><p>Cerebrospinal (CSF) markers and saliva melatonin measurements are not currently used clinically but may hold promise in the future.</p><p class="headingAnchor" id="H346528376"><span class="h2">Actigraphy</span><span class="headingEndMark"> — </span>Actigraphy records rest-activity patterns using an accelerometer to detect motion, often combined with a light detector, usually worn on the nondominant wrist. Actigraphy results are an objective counterpart to data obtained from a sleep diary. (See  <a class="medical medical_review" href="/z/d/html/107759.html" rel="external">"Actigraphy in the evaluation of sleep disorders"</a>.)</p><p>Although not widely available for clinical purposes in the United States and moderately expensive, actigraphy can be useful as an objective measure of sleep-wake patterns in patients with a complaint of excessive daytime sleepiness. It also has the advantage over PSG of recording activity patterns over long periods of time (ie, weeks to months). An actigraphy pattern showing much longer sleep times on weekends than weekdays supports a diagnosis of insufficient sleep syndrome in patients with a complaint of daytime sleepiness.</p><p>Consumer wearable devices with sleep-tracking technologies, on the other hand, might appeal as an attractive alternative to actigraphy and in-laboratory sleep testing. However, implementation of most devices into clinical practice is limited by insufficient or absent validation and accuracy studies. (See  <a class="medical medical_review" href="/z/d/html/107759.html" rel="external">"Actigraphy in the evaluation of sleep disorders", section on 'Consumer wearable devices'</a>.)</p><p>Actigraphy has been used in many studies of adult patients with TBI [<a href="#rid13">13,17,42,51,95,96</a>], though caution should be exercised regarding using activity as a surrogate for sleep in patients with locomotor limitations including spasticity, paresis, depression, and/or agitation. Even in the absence of these limitations, actigraphy may underestimate the level of sleep disruption compared with polysomnography [<a href="#rid97">97</a>].</p><p>Actigraphy may be particularly useful in confirming rest-activity patterns in patients with suspected Kleine-Levin syndrome associated with TBI. (See <a class="local">'Excessive daytime sleepiness'</a> above.)</p><p class="headingAnchor" id="H1195604"><span class="h2">Polysomnography</span><span class="headingEndMark"> — </span>PSG is not necessary in all patients with sleep-wake complaints but should be obtained in selected patients, based on the history. Given the higher prevalence of sleep-wake disorders in patients with TBI, there should be a low threshold to obtain PSG for any sleep history or complaint that is suspicious for sleep apnea (eg, excessive daytime sleepiness, snoring, comorbid obesity) or hypersomnia. (See  <a class="medical medical_review" href="/z/d/html/7696.html" rel="external">"Overview of polysomnography in adults"</a>.)</p><p>If obstructive sleep apnea (OSA) is the overriding suspicion based on the history, home sleep apnea testing is an alternative to in-laboratory PSG. (See  <a class="medical medical_review" href="/z/d/html/7694.html" rel="external">"Home sleep apnea testing for obstructive sleep apnea in adults"</a>.)</p><p class="headingAnchor" id="H967834"><span class="h2">Multiple sleep latency test</span><span class="headingEndMark"> — </span>Like PSG, an MSLT is not necessary in all patients with sleep-wake complaints but is suggested in selected patients, particularly those with a chief complaint of excessive daytime sleepiness who have had sleep apnea ruled out by PSG. (See  <a class="medical medical_review" href="/z/d/html/7688.html" rel="external">"Quantifying sleepiness", section on 'Multiple sleep latency test (MSLT)'</a>.)</p><p>A mean sleep latency less than eight minutes is generally considered to be objective evidence of excessive daytime sleepiness. Several specific sleep disorders can also be diagnosed in the appropriate clinical setting. Examples include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>If excessive daytime sleepiness persists for three months after TBI with a mean sleep-onset latency of less than eight minutes and with fewer than two sleep-onset rapid eye movement (REM) periods, then the diagnosis is "hypersomnia caused by medical condition," or "posttraumatic hypersomnia" [<a href="#rid98">98</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the case of a short mean sleep-onset latency and the occurrence of multiple sleep-onset REM periods (SOREMPs), "posttraumatic narcolepsy" or "narcolepsy caused by medical condition" should be distinguished from insufficient sleep syndrome (ie, chronic sleep deprivation), which can also present with enhanced REM sleep pressure [<a href="#rid99">99</a>].</p><p></p><p class="headingAnchor" id="H1195610"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Treatment of sleep-wake disturbances after TBI depends on the dominant symptom or specific sleep-wake disorder and relevant comorbidities  (<a class="graphic graphic_figure graphicRef131183" href="/z/d/graphic/131183.html" rel="external">figure 1</a>). The goals of treatment are symptom mitigation, functional recovery, and improvement in quality of life [<a href="#rid13">13,100,101</a>]. </p><p class="headingAnchor" id="H4070056906"><span class="h2">Symptom-directed therapy</span></p><p class="headingAnchor" id="H1195618"><span class="h3">Excessive daytime sleepiness</span><span class="headingEndMark"> — </span>Excessive daytime sleepiness is often multifactorial. Any underlying conditions identified during the evaluation that may contribute to daytime sleepiness should be addressed and treated, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Depression and anxiety</p><p class="bulletIndent1"><span class="glyph">●</span>Obstructive sleep apnea (OSA)</p><p class="bulletIndent1"><span class="glyph">●</span>Circadian sleep-wake rhythm disturbances, such as delayed sleep-wake phase disorder</p><p class="bulletIndent1"><span class="glyph">●</span>Restless legs syndrome</p><p class="bulletIndent1"><span class="glyph">●</span>Insufficient sleep</p><p class="bulletIndent1"><span class="glyph">●</span>Adverse effects from medications; if feasible, discontinue the medication or change the timing of administration</p><p></p><p>For patients with persistent symptoms or no other identifiable causes, pharmacologic treatment options include wakefulness-promoting agents (<a class="drug drug_general" data-topicid="10157" href="/z/d/drug information/10157.html" rel="external">modafinil</a>, <a class="drug drug_general" data-topicid="9260" href="/z/d/drug information/9260.html" rel="external">armodafinil</a>) and stimulants such as <a class="drug drug_general" data-topicid="9638" href="/z/d/drug information/9638.html" rel="external">methylphenidate</a>. Of these, we suggest modafinil or armodafinil as first-line therapy, based on supporting data in case reports and two small placebo-controlled randomized trials in patients with TBI, as well as indirect data from larger randomized trials in patients with narcolepsy [<a href="#rid102">102-105</a>]. Methylphenidate is an alternative to modafinil and armodafinil that is less well studied in patients with TBI [<a href="#rid106">106,107</a>].</p><p><a class="drug drug_general" data-topicid="10157" href="/z/d/drug information/10157.html" rel="external">Modafinil</a> is typically started at a dose of 100 mg twice daily (first dose upon awakening, second dose at midday) and can be titrated up to 200 mg twice daily as needed by symptomatic benefit. <a class="drug drug_general" data-topicid="9260" href="/z/d/drug information/9260.html" rel="external">Armodafinil</a> has a longer half-life and is typically dosed at 50, 150, or 250 mg once daily in the morning.</p><p>In a randomized, placebo-controlled, multicenter trial of 117 adults with a history of TBI, baseline Epworth Sleepiness Scale (ESS) score ≥10, and sleep latency less than eight minutes on a multiple sleep latency test (MSLT), patients treated with <a class="drug drug_general" data-topicid="9260" href="/z/d/drug information/9260.html" rel="external">armodafinil</a> 250 mg daily for 12 weeks showed significant improvement in sleep latency compared with placebo (+7.2 versus +2.4 minutes) [<a href="#rid102">102</a>]. Subjective sleepiness was improved on some measures but not others at various doses of armodafinil (50, 150, or 250 mg/day). Similar results were reported in a smaller randomized trial of <a class="drug drug_general" data-topicid="10157" href="/z/d/drug information/10157.html" rel="external">modafinil</a> [<a href="#rid103">103</a>]. Modafinil and armodafinil were well tolerated in both trials; headache is the most common side effect of both drugs.</p><p>Morning bright light therapy has been studied as a nonpharmacologic treatment option in posttraumatic fatigue and may also have some benefit for daytime sleepiness. The premise of light therapy is to help subclinical circadian sleep-wake rhythm disturbances that may be contributing to sleepiness. Four small trials in patients with TBI and persistent fatigue found significant reductions in fatigue and daytime sleepiness after four or six weeks of morning blue or white light therapy compared with placebo or no treatment [<a href="#rid108">108-112</a>].</p><p>Other novel treatments being studied include dietary supplementation with branched chain amino acids (BCAAs), which improved wakefulness and cognition in an animal model of mild to moderate TBI [<a href="#rid22">22,113</a>]. The mechanism of action of BCAAs was the restoration of excitatory glutamate within presynaptic terminals on wake-promoting orexin neurons in the hypothalamus [<a href="#rid24">24</a>]. A small double-blind, placebo-controlled randomized trial of BCAA supplementation in 32 veterans in the chronic phase of recovery from TBI found improvements in both subjective insomnia severity and actigraphically-determined sleep measures, providing rationale for larger studies [<a href="#rid114">114</a>].</p><p class="headingAnchor" id="H1195630"><span class="h3">Insomnia</span><span class="headingEndMark"> — </span>Pharmacologic and behavioral approaches for insomnia in patients with a history of TBI are generally similar to those in the general population. (See  <a class="medical medical_review" href="/z/d/html/97867.html" rel="external">"Overview of the treatment of insomnia in adults"</a>.)</p><p>In patients with TBI, special consideration should be paid to cognitive impairment, which may increase the risk of side effects from sedative/hypnotic medications, and comorbid affective disorders, which are common in patients with TBI and may require additional therapy.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Behavioral approaches</strong> – Cognitive-behavioral therapy for insomnia (CBT-I) and acupuncture are the best studied approaches in patients with TBI [<a href="#rid115">115-118</a>]. A systematic review of 10 studies on behavioral interventions to improve sleep after TBI found evidence to support CBT-I, sleep-hygiene-related interventions, alone or in combination with other treatments, and morning blue light therapy [<a href="#rid119">119</a>].</p><p></p><p class="bulletIndent1">Acupuncture may have some benefit as well [<a href="#rid116">116,117</a>]. In a sham-controlled trial in 60 veterans with refractory sleep disturbance after mild TBI, twice weekly sessions of acupuncture for five weeks led to modest short-term improvements in subjective and actigraphic sleep parameters, although benefits were not sustained at a four-week follow-up visit [<a href="#rid117">117</a>]. Treatment was well tolerated in patients with and without concurrent posttraumatic stress disorder (PTSD).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pharmacotherapy</strong> – With all pharmacologic therapies for insomnia, patients should be treated with the lowest effective dose and for the shortest time period possible [<a href="#rid120">120,121</a>]. Limited data in patients with TBI suggest that benzodiazepine and nonbenzodiazepine receptor agonists are similarly effective [<a href="#rid122">122</a>]. </p><p></p><p class="bulletIndent1">Melatonin has appeal based on its circadian effects and relative safety. However, supportive evidence for a clinical benefit of melatonin in patients with insomnia associated with TBI is limited [<a href="#rid123">123-125</a>]. In a crossover randomized trial of 33 adults recovering from TBI, melatonin improved subjective sleep quality and some objective measures of sleep quality, increased sleep efficiency, and reduced anxiety without causing daytime sleepiness [<a href="#rid124">124</a>]. A trial in children aged 8 to 18 years with persistent postconcussion symptoms found that 3 or 10 mg of melatonin increased sleep duration, and the higher dose improved sleep efficiency [<a href="#rid126">126</a>]. </p><p></p><p class="headingAnchor" id="H4070056925"><span class="h3">Pleiosomnia</span><span class="headingEndMark"> — </span>There are no specific therapies for increased sleep need after TBI. Nonetheless, the symptom can be quite disturbing to patients, particularly those with a sleep need of 12 hours per day or more. Reassurance that the symptom is common after TBI may be helpful.</p><p>One possibility is that increased sleep need represents a necessary physiologic response to the injured brain; if this is the case, curtailing sleep could counteract a necessary healing response. On the other hand, pleiosomnia might be solely due to damage to wake-maintaining systems. In this case, tailored treatment strategies may emerge in the future.</p><p class="headingAnchor" id="H4070056958"><span class="h2">Specific disorders</span></p><p class="headingAnchor" id="H1195642"><span class="h3">Circadian sleep-wake rhythm disorders</span><span class="headingEndMark"> — </span>Therapeutic approaches to circadian sleep-wake rhythm disorders in the general population include behavioral modifications, light therapy, and melatonin. (See  <a class="medical medical_review" href="/z/d/html/97845.html" rel="external">"Delayed sleep-wake phase disorder", section on 'Management'</a>.)</p><p>These approaches have been used with some success in patients with TBI in case reports and small studies [<a href="#rid123">123,127</a>]. Melatonin (5 mg) and <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">amitriptyline</a> (25 mg) were examined in a pilot randomized, placebo-controlled crossover study of seven patients with post-TBI chronic sleep disturbances [<a href="#rid123">123</a>]. While there were no significant differences in sleep latency, duration, quality, or daytime alertness for either drug compared with baseline, melatonin was associated with a trend towards improved daytime alertness, and patients on amitriptyline reported increased sleep duration.</p><p class="headingAnchor" id="H4070056965"><span class="h3">Parasomnias</span><span class="headingEndMark"> — </span>Parasomnias seen in the post-TBI population include non-rapid eye movement (NREM) parasomnias such as nightmares and rapid eye movement (REM) sleep behavior disorder (RBD).</p><p>All parasomnias are exacerbated by sleep deprivation or sleep fragmentation, and therefore the first-line approach to treatment is to identify and treat causes of poor sleep quality (ie, improve sleep hygiene, avoid alcohol, treat sleep apnea and restless legs syndrome).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nightmares</strong> – PTSD-related nightmares can be effectively treated with <a class="drug drug_general" data-topicid="9806" href="/z/d/drug information/9806.html" rel="external">prazosin</a> and/or image-rehearsal therapy with or without CBT-I [<a href="#rid128">128</a>]. If parasomnias persist despite treatment of secondary causes, and are bothersome to the patient, low-dose <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">clonazepam</a> is often helpful (ie, 0.5 to 2 mg nightly). Management of nightmares with and without comorbid PTSD is reviewed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/117909.html" rel="external">"Posttraumatic stress disorder in adults: Treatment overview"</a> and  <a class="medical medical_review" href="/z/d/html/97872.html" rel="external">"Nightmares and nightmare disorder in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>RBD </strong>– In patients with RBD, which can result in violent dream enactment, establishing a safe sleeping environment is the primary goal of treatment. This can be achieved through modification of the sleep environment and pharmacotherapy, if necessary. Medications known to cause or exacerbate RBD, such as serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and tricyclic antidepressants, should be discontinued or avoided if possible. Low-dose <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">clonazepam</a> and high-dose melatonin are effective therapies in patients with RBD characterized by frequent, disruptive or injurious behaviors. (See  <a class="medical medical_review" href="/z/d/html/14894.html" rel="external">"Rapid eye movement sleep behavior disorder", section on 'Management'</a>.)</p><p></p><p class="bulletIndent1">In patients with purported "trauma-associated sleep disorder," which may or may not be nosologically distinct from idiopathic RBD, dream enactment behavior is instead characterized by a triggering traumatic event and autonomic hyperarousal [<a href="#rid58">58,59,129</a>]. The treatment of choice has been reported anecdotally to be <a class="drug drug_general" data-topicid="9806" href="/z/d/drug information/9806.html" rel="external">prazosin</a>, rather than <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">clonazepam</a> and melatonin [<a href="#rid60">60</a>]. However, it should be noted that prazosin failed to show benefit in alleviating distressing dreams or sleep quality in a large multisite randomized clinical trial of 304 veterans with chronic PTSD [<a href="#rid130">130</a>]. (See  <a class="medical medical_review" href="/z/d/html/97872.html" rel="external">"Nightmares and nightmare disorder in adults", section on 'Prazosin'</a>.)</p><p></p><p class="headingAnchor" id="H964474"><span class="h3">Obstructive sleep apnea</span><span class="headingEndMark"> — </span>Behavioral modifications, including weight loss, and positive airway pressure (PAP) therapy are the cornerstones of therapy for OSA. Both have been shown to improve outcomes in the general population in randomized trials [<a href="#rid131">131-133</a>], and their effects may be additive [<a href="#rid134">134</a>]. (See  <a class="medical medical_review" href="/z/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Goals of PAP therapy'</a>.)</p><p>Individuals with OSA in the post-TBI setting should be treated similarly, although literature in this patient population is sparse. In the one study that examined continuous PAP (CPAP) therapy in patients with TBI, CPAP therapy was associated with a decreased apnea hypopnea index (AHI) and improved sleep quality three months after administration, but it did not improve excessive daytime sleepiness as measured by the MSLT [<a href="#rid135">135</a>]. CPAP adherence and medication side effects were not taken into account, however, which could explain the lack of improvement in daytime sleepiness.</p><p>The potential consequences of untreated OSA in patients with TBI were illustrated by a small case control study that included 19 TBI patients with OSA and 16 TBI patients without OSA on nocturnal polysomnography [<a href="#rid136">136</a>]. Patients with OSA performed significantly worse than those without OSA on tasks of sustained attention and memory. Such deleterious effect of OSA on cognition has been confirmed in 60 patients with moderate to severe TBI [<a href="#rid137">137</a>].</p><p class="headingAnchor" id="H1414136188"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/116408.html" rel="external">"Society guideline links: Increased intracranial pressure and moderate-to-severe traumatic brain injury"</a>.)</p><p class="headingAnchor" id="H4070056894"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Sleep-wake disturbances arise in approximately one-third of patients in the acute phase after mild traumatic brain injury (TBI) and approximately half of patients in the chronic phase. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mechanisms</strong> – The pathophysiology of posttraumatic sleep-wake disturbances may be explained in part by reductions in wake-promoting neurotransmitters such as orexin and histamine. (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – The most common manifestations are excessive daytime sleepiness, increased sleep need (pleiosomnia), and insomnia  (<a class="graphic graphic_figure graphicRef131183" href="/z/d/graphic/131183.html" rel="external">figure 1</a>). (See <a class="local">'Excessive daytime sleepiness'</a> above and <a class="local">'Increased sleep need (pleiosomnia)'</a> above and <a class="local">'Insomnia'</a> above.)</p><p></p><p class="bulletIndent1">Less commonly, patients experience circadian sleep-wake rhythm disturbances; abnormal movements or behaviors during sleep, such as sleep talking, bruxism, and dream enactment; and sleep-disordered breathing. (See <a class="local">'Circadian sleep-wake rhythm disturbances'</a> above and <a class="local">'Abnormal movements or behaviors during sleep'</a> above and <a class="local">'Sleep-disordered breathing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – Sleep-wake disorders are diagnosed by history, supplemented by objective sleep testing in selected patients. The goals of the evaluation are threefold (see <a class="local">'History'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Refine the sleep complaint through a comprehensive sleep history</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Diagnose specific treatable sleep disorders</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Identify medical and psychiatric comorbidities that may be contributing to the sleep disturbances</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Treatment varies according to the dominant symptom or specific sleep disorder as well as relevant comorbidities. Treatment strategies in patients with a history of TBI are generally similar to those in the general population  (<a class="graphic graphic_figure graphicRef131183" href="/z/d/graphic/131183.html" rel="external">figure 1</a>). (See <a class="local">'Symptom-directed therapy'</a> above and <a class="local">'Specific disorders'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Excessive sleepiness</strong> – In patients with TBI who have persistent and bothersome excessive daytime sleepiness that cannot be explained by other causes or comorbidities, we suggest treatment with a wake-promoting agent such as <a class="drug drug_general" data-topicid="10157" href="/z/d/drug information/10157.html" rel="external">modafinil</a> (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). A stimulant such as <a class="drug drug_general" data-topicid="9638" href="/z/d/drug information/9638.html" rel="external">methylphenidate</a> is an alternative therapy that has not been well studied in patients with TBI. (See <a class="local">'Excessive daytime sleepiness'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Insomnia</strong> – Pharmacologic and behavioral approaches for insomnia in patients with a history of TBI are generally similar to those in the general population. Special consideration should be paid to cognitive impairment, which may increase the risk of side effects from sedative/hypnotic medications, and comorbid affective disorders, which are common in patients with TBI and may require additional therapy. (See <a class="local">'Insomnia'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Duclos C, Dumont M, Wiseman-Hakes C, et al. Sleep and wake disturbances following traumatic brain injury. Pathol Biol (Paris) 2014; 62:252.</a></li><li><a class="nounderline abstract_t">Orff HJ, Ayalon L, Drummond SP. Traumatic brain injury and sleep disturbance: a review of current research. J Head Trauma Rehabil 2009; 24:155.</a></li><li><a class="nounderline abstract_t">Sandsmark DK, Elliott JE, Lim MM. Sleep-Wake Disturbances After Traumatic Brain Injury: Synthesis of Human and Animal Studies. Sleep 2017; 40.</a></li><li><a class="nounderline abstract_t">Baumann CR. Traumatic brain injury and disturbed sleep and wakefulness. Neuromolecular Med 2012; 14:205.</a></li><li><a class="nounderline abstract_t">Castriotta RJ, Wilde MC, Lai JM, et al. Prevalence and consequences of sleep disorders in traumatic brain injury. J Clin Sleep Med 2007; 3:349.</a></li><li><a class="nounderline abstract_t">Ouellet MC, Beaulieu-Bonneau S, Morin CM. Insomnia in patients with traumatic brain injury: frequency, characteristics, and risk factors. J Head Trauma Rehabil 2006; 21:199.</a></li><li><a class="nounderline abstract_t">Leng Y, Byers AL, Barnes DE, et al. Traumatic Brain Injury and Incidence Risk of Sleep Disorders in Nearly 200,000 US Veterans. Neurology 2021; 96:e1792.</a></li><li><a class="nounderline abstract_t">Chaput G, Giguère JF, Chauny JM, et al. Relationship among subjective sleep complaints, headaches, and mood alterations following a mild traumatic brain injury. Sleep Med 2009; 10:713.</a></li><li><a class="nounderline abstract_t">King NS, Crawford S, Wenden FJ, et al. The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol 1995; 242:587.</a></li><li><a class="nounderline abstract_t">Haboubi NH, Long J, Koshy M, Ward AB. Short-term sequelae of minor head injury (6 years experience of minor head injury clinic). Disabil Rehabil 2001; 23:635.</a></li><li><a class="nounderline abstract_t">Theadom A, Cropley M, Parmar P, et al. Sleep difficulties one year following mild traumatic brain injury in a population-based study. Sleep Med 2015; 16:926.</a></li><li><a class="nounderline abstract_t">Djukic S, Phillips NL, Lah S. Sleep outcomes in pediatric mild traumatic brain injury: a systematic review and meta-analysis of prevalence and contributing factors. Brain Inj 2022; 36:1289.</a></li><li><a class="nounderline abstract_t">Makley MJ, Johnson-Greene L, Tarwater PM, et al. Return of memory and sleep efficiency following moderate to severe closed head injury. Neurorehabil Neural Repair 2009; 23:320.</a></li><li><a class="nounderline abstract_t">Nakase-Richardson R, Sherer M, Barnett SD, et al. Prospective evaluation of the nature, course, and impact of acute sleep abnormality after traumatic brain injury. Arch Phys Med Rehabil 2013; 94:875.</a></li><li><a class="nounderline abstract_t">Mathias JL, Alvaro PK. Prevalence of sleep disturbances, disorders, and problems following traumatic brain injury: a meta-analysis. Sleep Med 2012; 13:898.</a></li><li><a class="nounderline abstract_t">Ouellet MC, Morin CM. Subjective and objective measures of insomnia in the context of traumatic brain injury: a preliminary study. Sleep Med 2006; 7:486.</a></li><li><a class="nounderline abstract_t">Baumann CR, Werth E, Stocker R, et al. Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain 2007; 130:1873.</a></li><li><a class="nounderline abstract_t">Kempf J, Werth E, Kaiser PR, et al. Sleep-wake disturbances 3 years after traumatic brain injury. J Neurol Neurosurg Psychiatry 2010; 81:1402.</a></li><li><a class="nounderline abstract_t">Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005; 437:1257.</a></li><li><a class="nounderline abstract_t">Baumann CR, Stocker R, Imhof HG, et al. Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury. Neurology 2005; 65:147.</a></li><li><a class="nounderline abstract_t">Baumann CR, Bassetti CL, Valko PO, et al. Loss of hypocretin (orexin) neurons with traumatic brain injury. Ann Neurol 2009; 66:555.</a></li><li><a class="nounderline abstract_t">Lim MM, Elkind J, Xiong G, et al. Dietary therapy mitigates persistent wake deficits caused by mild traumatic brain injury. Sci Transl Med 2013; 5:215ra173.</a></li><li><a class="nounderline abstract_t">Willie JT, Lim MM, Bennett RE, et al. Controlled cortical impact traumatic brain injury acutely disrupts wakefulness and extracellular orexin dynamics as determined by intracerebral microdialysis in mice. J Neurotrauma 2012; 29:1908.</a></li><li><a class="nounderline abstract_t">Elliott JE, De Luche SE, Churchill MJ, et al. Dietary therapy restores glutamatergic input to orexin/hypocretin neurons after traumatic brain injury in mice. Sleep 2018; 41.</a></li><li><a class="nounderline abstract_t">Valko PO, Gavrilov YV, Yamamoto M, et al. Damage to histaminergic tuberomammillary neurons and other hypothalamic neurons with traumatic brain injury. Ann Neurol 2015; 77:177.</a></li><li><a class="nounderline abstract_t">Valko PO, Gavrilov YV, Yamamoto M, et al. Damage to Arousal-Promoting Brainstem Neurons with Traumatic Brain Injury. Sleep 2016; 39:1249.</a></li><li><a class="nounderline abstract_t">Naseem M, Parvez S. Role of melatonin in traumatic brain injury and spinal cord injury. ScientificWorldJournal 2014; 2014:586270.</a></li><li><a class="nounderline abstract_t">Shekleton JA, Parcell DL, Redman JR, et al. Sleep disturbance and melatonin levels following traumatic brain injury. Neurology 2010; 74:1732.</a></li><li><a class="nounderline abstract_t">Seifman MA, Gomes K, Nguyen PN, et al. Measurement of serum melatonin in intensive care unit patients: changes in traumatic brain injury, trauma, and medical conditions. Front Neurol 2014; 5:237.</a></li><li><a class="nounderline abstract_t">Grima NA, Ponsford JL, St Hilaire MA, et al. Circadian Melatonin Rhythm Following Traumatic Brain Injury. Neurorehabil Neural Repair 2016; 30:972.</a></li><li><a class="nounderline abstract_t">Imbach LL, Valko PO, Li T, et al. Increased sleep need and daytime sleepiness 6 months after traumatic brain injury: a prospective controlled clinical trial. Brain 2015; 138:726.</a></li><li><a class="nounderline abstract_t">Bianciardi M, Izzy S, Rosen BR, et al. Location of Subcortical Microbleeds and Recovery of Consciousness After Severe Traumatic Brain Injury. Neurology 2021; 97:e113.</a></li><li><a class="nounderline abstract_t">Collen J, Orr N, Lettieri CJ, et al. Sleep disturbances among soldiers with combat-related traumatic brain injury. Chest 2012; 142:622.</a></li><li><a class="nounderline abstract_t">Masel BE, Scheibel RS, Kimbark T, Kuna ST. Excessive daytime sleepiness in adults with brain injuries. Arch Phys Med Rehabil 2001; 82:1526.</a></li><li><a class="nounderline abstract_t">Watson NF, Dikmen S, Machamer J, et al. Hypersomnia following traumatic brain injury. J Clin Sleep Med 2007; 3:363.</a></li><li><a class="nounderline abstract_t">Young TB. Epidemiology of daytime sleepiness: definitions, symptomatology, and prevalence. J Clin Psychiatry 2004; 65 Suppl 16:12.</a></li><li class="breakAll">American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed, American Academy of Sleep Medicine, 2014.</li><li><a class="nounderline abstract_t">Ebrahim IO, Peacock KW, Williams AJ. Posttraumatic narcolepsy--two case reports and a mini review. J Clin Sleep Med 2005; 1:153.</a></li><li><a class="nounderline abstract_t">Longstreth WT Jr, Koepsell TD, Ton TG, et al. The epidemiology of narcolepsy. Sleep 2007; 30:13.</a></li><li><a class="nounderline abstract_t">Imbach LL, Büchele F, Valko PO, et al. Sleep-wake disorders persist 18 months after traumatic brain injury but remain underrecognized. Neurology 2016; 86:1945.</a></li><li><a class="nounderline abstract_t">Arnulf I, Zeitzer JM, File J, et al. Kleine-Levin syndrome: a systematic review of 186 cases in the literature. Brain 2005; 128:2763.</a></li><li><a class="nounderline abstract_t">Sommerauer M, Valko PO, Werth E, Baumann CR. Excessive sleep need following traumatic brain injury: a case-control study of 36 patients. J Sleep Res 2013; 22:634.</a></li><li><a class="nounderline abstract_t">Beetar JT, Guilmette TJ, Sparadeo FR. Sleep and pain complaints in symptomatic traumatic brain injury and neurologic populations. Arch Phys Med Rehabil 1996; 77:1298.</a></li><li><a class="nounderline abstract_t">Clinchot DM, Bogner J, Mysiw WJ, et al. Defining sleep disturbance after brain injury. Am J Phys Med Rehabil 1998; 77:291.</a></li><li><a class="nounderline abstract_t">Montgomery MC, Baylan S, Gardani M. Prevalence of insomnia and insomnia symptoms following mild-traumatic brain injury: A systematic review and meta-analysis. Sleep Med Rev 2022; 61:101563.</a></li><li><a class="nounderline abstract_t">Bryan CJ. Repetitive traumatic brain injury (or concussion) increases severity of sleep disturbance among deployed military personnel. Sleep 2013; 36:941.</a></li><li><a class="nounderline abstract_t">Wickwire EM, Albrecht JS, Capaldi VF 2nd, et al. Trajectories of Insomnia in Adults After Traumatic Brain Injury. JAMA Netw Open 2022; 5:e2145310.</a></li><li><a class="nounderline abstract_t">Balba NM, Elliott JE, Weymann KB, et al. Increased Sleep Disturbances and Pain in Veterans With Comorbid Traumatic Brain Injury and Posttraumatic Stress Disorder. J Clin Sleep Med 2018; 14:1865.</a></li><li><a class="nounderline abstract_t">Colvonen PJ, Almklov E, Tripp JC, et al. Prevalence rates and correlates of insomnia disorder in post-9/11 veterans enrolling in VA healthcare. Sleep 2020; 43.</a></li><li><a class="nounderline abstract_t">Cantor JB, Bushnik T, Cicerone K, et al. Insomnia, fatigue, and sleepiness in the first 2 years after traumatic brain injury: an NIDRR TBI model system module study. J Head Trauma Rehabil 2012; 27:E1.</a></li><li><a class="nounderline abstract_t">Duclos C, Dumont M, Blais H, et al. Rest-Activity Cycle Disturbances in the Acute Phase of Moderate to Severe Traumatic Brain Injury. Neurorehabil Neural Repair 2014; 28:472.</a></li><li><a class="nounderline abstract_t">Williams BR, Lazic SE, Ogilvie RD. Polysomnographic and quantitative EEG analysis of subjects with long-term insomnia complaints associated with mild traumatic brain injury. Clin Neurophysiol 2008; 119:429.</a></li><li><a class="nounderline abstract_t">Weitzman ED, Czeisler CA, Zimmerman JC, Moore-Ede MC. Biological rhythms in man: relationship of sleep-wake, cortisol, growth hormone, and temperature during temporal isolation. Adv Biochem Psychopharmacol 1981; 28:475.</a></li><li><a class="nounderline abstract_t">Zalai DM, Girard TA, Cusimano MD, Shapiro CM. Circadian rhythm in the assessment of postconcussion insomnia: a cross-sectional observational study. CMAJ Open 2020; 8:E142.</a></li><li><a class="nounderline abstract_t">Kaufman Y, Tzischinsky O, Epstein R, et al. Long-term sleep disturbances in adolescents after minor head injury. Pediatr Neurol 2001; 24:129.</a></li><li><a class="nounderline abstract_t">Verma A, Anand V, Verma NP. Sleep disorders in chronic traumatic brain injury. J Clin Sleep Med 2007; 3:357.</a></li><li><a class="nounderline abstract_t">Elliott JE, Opel RA, Pleshakov D, et al. Posttraumatic stress disorder increases the odds of REM sleep behavior disorder and other parasomnias in Veterans with and without comorbid traumatic brain injury. Sleep 2020; 43.</a></li><li><a class="nounderline abstract_t">Mysliwiec V, Brock MS, Creamer JL, et al. Trauma associated sleep disorder: A parasomnia induced by trauma. Sleep Med Rev 2018; 37:94.</a></li><li><a class="nounderline abstract_t">Rachakonda TD, Balba NM, Lim MM. Trauma-Associated Sleep Disturbances: a Distinct Sleep Disorder? Curr Sleep Med Rep 2018; 4:143.</a></li><li><a class="nounderline abstract_t">Mysliwiec V, O'Reilly B, Polchinski J, et al. Trauma associated sleep disorder: a proposed parasomnia encompassing disruptive nocturnal behaviors, nightmares, and REM without atonia in trauma survivors. J Clin Sleep Med 2014; 10:1143.</a></li><li><a class="nounderline abstract_t">Mysliwiec V, Brock MS. Time to recognize trauma associated sleep disorder as a distinct parasomnia. Sleep 2020; 43.</a></li><li><a class="nounderline abstract_t">Mellman TA. A time to recognize trauma-related sleep disorder or a time to pause and consider? Sleep 2020; 43.</a></li><li><a class="nounderline abstract_t">White DL, Kunik ME, Yu H, et al. Post-Traumatic Stress Disorder is Associated with further Increased Parkinson's Disease Risk in Veterans with Traumatic Brain Injury. Ann Neurol 2020; 88:33.</a></li><li><a class="nounderline abstract_t">Webster JB, Bell KR, Hussey JD, et al. Sleep apnea in adults with traumatic brain injury: a preliminary investigation. Arch Phys Med Rehabil 2001; 82:316.</a></li><li><a class="nounderline abstract_t">Guilleminault C, Yuen KM, Gulevich MG, et al. Hypersomnia after head-neck trauma: a medicolegal dilemma. Neurology 2000; 54:653.</a></li><li><a class="nounderline abstract_t">Capaldi VF 2nd, Guerrero ML, Killgore WD. Sleep disruptions among returning combat veterans from Iraq and Afghanistan. Mil Med 2011; 176:879.</a></li><li><a class="nounderline abstract_t">Chaumet G, Quera-Salva MA, Macleod A, et al. Is there a link between alertness and fatigue in patients with traumatic brain injury? Neurology 2008; 71:1609.</a></li><li><a class="nounderline abstract_t">Mysliwiec V, Gill J, Lee H, et al. Sleep disorders in US military personnel: a high rate of comorbid insomnia and obstructive sleep apnea. Chest 2013; 144:549.</a></li><li><a class="nounderline abstract_t">Koponen S, Taiminen T, Hiekkanen H, Tenovuo O. Axis I and II psychiatric disorders in patients with traumatic brain injury: a 12-month follow-up study. Brain Inj 2011; 25:1029.</a></li><li><a class="nounderline abstract_t">Ashman TA, Spielman LA, Hibbard MR, et al. Psychiatric challenges in the first 6 years after traumatic brain injury: cross-sequential analyses of Axis I disorders. Arch Phys Med Rehabil 2004; 85:S36.</a></li><li><a class="nounderline abstract_t">Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289:3095.</a></li><li><a class="nounderline abstract_t">Ponsford JL, Parcell DL, Sinclair KL, et al. Changes in sleep patterns following traumatic brain injury: a controlled study. Neurorehabil Neural Repair 2013; 27:613.</a></li><li><a class="nounderline abstract_t">Ponsford JL, Ziino C, Parcell DL, et al. Fatigue and sleep disturbance following traumatic brain injury--their nature, causes, and potential treatments. J Head Trauma Rehabil 2012; 27:224.</a></li><li><a class="nounderline abstract_t">Pigeon WR, Campbell CE, Possemato K, Ouimette P. Longitudinal relationships of insomnia, nightmares, and PTSD severity in recent combat veterans. J Psychosom Res 2013; 75:546.</a></li><li><a class="nounderline abstract_t">Kennedy JE, Leal FO, Lewis JD, et al. Posttraumatic stress symptoms in OIF/OEF service members with blast-related and non-blast-related mild TBI. NeuroRehabilitation 2010; 26:223.</a></li><li><a class="nounderline abstract_t">Williamson JB, Heilman KM, Porges EC, et al. A possible mechanism for PTSD symptoms in patients with traumatic brain injury: central autonomic network disruption. Front Neuroeng 2013; 6:13.</a></li><li class="breakAll">Zasler ND, Martelli MF, Nicholson K. Chronic Pain. In: Textbook of Traumatic Brain Injury, Silver JM, McAllister TW, Yudofsky SC (Eds), American Psychiatric Publishing, Arlington 2011.</li><li><a class="nounderline abstract_t">Nampiaparampil DE. Prevalence of chronic pain after traumatic brain injury: a systematic review. JAMA 2008; 300:711.</a></li><li class="breakAll">Lavigne G. Pain and Sleep. In: Principles and Practice of Sleep Medicine, Kryger MH, Roth T, Dement WC (Eds), Elsevier, 2011.</li><li><a class="nounderline abstract_t">Rao V, Bergey A, Hill H, et al. Sleep disturbance after mild traumatic brain injury: indicator of injury? J Neuropsychiatry Clin Neurosci 2011; 23:201.</a></li><li><a class="nounderline abstract_t">Khoury S, Chouchou F, Amzica F, et al. Rapid EEG activity during sleep dominates in mild traumatic brain injury patients with acute pain. J Neurotrauma 2013; 30:633.</a></li><li><a class="nounderline abstract_t">Feige B, Baglioni C, Spiegelhalder K, et al. The microstructure of sleep in primary insomnia: an overview and extension. Int J Psychophysiol 2013; 89:171.</a></li><li><a class="nounderline abstract_t">Sandsmark DK, Kumar MA, Woodward CS, et al. Sleep Features on Continuous Electroencephalography Predict Rehabilitation Outcomes After Severe Traumatic Brain Injury. J Head Trauma Rehabil 2016; 31:101.</a></li><li><a class="nounderline abstract_t">Sanchez E, Blais H, Duclos C, et al. Sleep from acute to chronic traumatic brain injury and cognitive outcomes. Sleep 2022; 45.</a></li><li><a class="nounderline abstract_t">Kalmbach DA, Conroy DA, Falk H, et al. Poor sleep is linked to impeded recovery from traumatic brain injury. Sleep 2018; 41.</a></li><li><a class="nounderline abstract_t">Mantua J, Grillakis A, Mahfouz SH, et al. A systematic review and meta-analysis of sleep architecture and chronic traumatic brain injury. Sleep Med Rev 2018; 41:61.</a></li><li><a class="nounderline abstract_t">Kinney AR, Adams RS, Caban JJ, et al. Intensive Outpatient Program Response Among Service Members With Mild Traumatic Brain Injury: Change Between Distinct Post-Concussive Symptom Subgroups. Arch Phys Med Rehabil 2023; 104:892.</a></li><li><a class="nounderline abstract_t">Mollayeva T, Colantonio A, Mollayeva S, Shapiro CM. Screening for sleep dysfunction after traumatic brain injury. Sleep Med 2013; 14:1235.</a></li><li><a class="nounderline abstract_t">Ownsworth T, Fleming J, Strong J, et al. Awareness typologies, long-term emotional adjustment and psychosocial outcomes following acquired brain injury. Neuropsychol Rehabil 2007; 17:129.</a></li><li><a class="nounderline abstract_t">Parcell DL, Ponsford JL, Redman JR, Rajaratnam SM. Poor sleep quality and changes in objectively recorded sleep after traumatic brain injury: a preliminary study. Arch Phys Med Rehabil 2008; 89:843.</a></li><li><a class="nounderline abstract_t">Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28:193.</a></li><li><a class="nounderline abstract_t">Fictenberg NL, Putnam SH, Mann NR, et al. Insomnia screening in postacute traumatic brain injury: utility and validity of the Pittsburgh Sleep Quality Index. Am J Phys Med Rehabil 2001; 80:339.</a></li><li><a class="nounderline abstract_t">Mollayeva T, Kendzerska T, Colantonio A. Self-report instruments for assessing sleep dysfunction in an adult traumatic brain injury population: a systematic review. Sleep Med Rev 2013; 17:411.</a></li><li><a class="nounderline abstract_t">Duffield TC, Lim MM, Novak M, et al. The relationship between depressive symptoms, somatic complaints, and concussion history with poor sleep in collegiate athletes. Sleep Health 2021; 7:43.</a></li><li><a class="nounderline abstract_t">Zollman FS, Cyborski C, Duraski SA. Actigraphy for assessment of sleep in traumatic brain injury: case series, review of the literature and proposed criteria for use. Brain Inj 2010; 24:748.</a></li><li><a class="nounderline abstract_t">Sinclair KL, Ponsford J, Rajaratnam SM. Actigraphic assessment of sleep disturbances following traumatic brain injury. Behav Sleep Med 2014; 12:13.</a></li><li><a class="nounderline abstract_t">Zeitzer JM, Hon F, Whyte J, et al. Coherence Between Sleep Detection by Actigraphy and Polysomnography in a Multi-Center, Inpatient Cohort of Individuals with Traumatic Brain Injury. PM R 2020; 12:1205.</a></li><li class="breakAll">The International Classification of Sleep Disorders: Diagnostic and Coding Manual, 2nd ed, American Academy of Sleep Medicine, Westchester, IL 2005.</li><li><a class="nounderline abstract_t">Marti I, Valko PO, Khatami R, et al. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome. Sleep Med 2009; 10:1146.</a></li><li><a class="nounderline abstract_t">Makley MJ, English JB, Drubach DA, et al. Prevalence of sleep disturbance in closed head injury patients in a rehabilitation unit. Neurorehabil Neural Repair 2008; 22:341.</a></li><li><a class="nounderline abstract_t">Wiseman-Hakes C, Murray B, Moineddin R, et al. Evaluating the impact of treatment for sleep/wake disorders on recovery of cognition and communication in adults with chronic TBI. Brain Inj 2013; 27:1364.</a></li><li><a class="nounderline abstract_t">Menn SJ, Yang R, Lankford A. Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension. J Clin Sleep Med 2014; 10:1181.</a></li><li><a class="nounderline abstract_t">Kaiser PR, Valko PO, Werth E, et al. Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury. Neurology 2010; 75:1780.</a></li><li><a class="nounderline abstract_t">Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2021; 17:1881.</a></li><li><a class="nounderline abstract_t">Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2021; 17:1895.</a></li><li><a class="nounderline abstract_t">Bassetti C, Aldrich MS. Idiopathic hypersomnia. A series of 42 patients. Brain 1997; 120 ( Pt 8):1423.</a></li><li><a class="nounderline abstract_t">Francisco GE, Ivanhoe CB. Successful treatment of post-traumatic narcolepsy with methylphenidate: a case report. Am J Phys Med Rehabil 1996; 75:63.</a></li><li><a class="nounderline abstract_t">Sinclair KL, Ponsford JL, Taffe J, et al. Randomized controlled trial of light therapy for fatigue following traumatic brain injury. Neurorehabil Neural Repair 2014; 28:303.</a></li><li><a class="nounderline abstract_t">Quera Salva MA, Azabou E, Hartley S, et al. Blue-Enriched White Light Therapy Reduces Fatigue in Survivors of Severe Traumatic Brain Injury: A Randomized Controlled Trial. J Head Trauma Rehabil 2020; 35:E78.</a></li><li><a class="nounderline abstract_t">Killgore WDS, Vanuk JR, Shane BR, et al. A randomized, double-blind, placebo-controlled trial of blue wavelength light exposure on sleep and recovery of brain structure, function, and cognition following mild traumatic brain injury. Neurobiol Dis 2020; 134:104679.</a></li><li><a class="nounderline abstract_t">Raikes AC, Dailey NS, Shane BR, et al. Daily Morning Blue Light Therapy Improves Daytime Sleepiness, Sleep Quality, and Quality of Life Following a Mild Traumatic Brain Injury. J Head Trauma Rehabil 2020; 35:E405.</a></li><li><a class="nounderline abstract_t">Elliott JE, McBride AA, Balba NM, et al. Feasibility and preliminary efficacy for morning bright light therapy to improve sleep and plasma biomarkers in US Veterans with TBI. A prospective, open-label, single-arm trial. PLoS One 2022; 17:e0262955.</a></li><li><a class="nounderline abstract_t">Elkind JA, Lim MM, Johnson BN, et al. Efficacy, dosage, and duration of action of branched chain amino Acid therapy for traumatic brain injury. Front Neurol 2015; 6:73.</a></li><li><a class="nounderline abstract_t">Elliott JE, Keil AT, Mithani S, et al. Dietary Supplementation With Branched Chain Amino Acids to Improve Sleep in Veterans With Traumatic Brain Injury: A Randomized Double-Blind Placebo-Controlled Pilot and Feasibility Trial. Front Syst Neurosci 2022; 16:854874.</a></li><li><a class="nounderline abstract_t">Ouellet MC, Morin CM. Efficacy of cognitive-behavioral therapy for insomnia associated with traumatic brain injury: a single-case experimental design. Arch Phys Med Rehabil 2007; 88:1581.</a></li><li><a class="nounderline abstract_t">Zollman FS, Larson EB, Wasek-Throm LK, et al. Acupuncture for treatment of insomnia in patients with traumatic brain injury: a pilot intervention study. J Head Trauma Rehabil 2012; 27:135.</a></li><li><a class="nounderline abstract_t">Huang W, Johnson TM, Kutner NG, et al. Acupuncture for Treatment of Persistent Disturbed Sleep: A Randomized Clinical Trial in Veterans With Mild Traumatic Brain Injury and Posttraumatic Stress Disorder. J Clin Psychiatry 2018; 80.</a></li><li><a class="nounderline abstract_t">Ford ME, Groet E, Daams JG, et al. Non-pharmacological treatment for insomnia following acquired brain injury: A systematic review. Sleep Med Rev 2020; 50:101255.</a></li><li><a class="nounderline abstract_t">Bogdanov S, Naismith S, Lah S. Sleep outcomes following sleep-hygiene-related interventions for individuals with traumatic brain injury: A systematic review. Brain Inj 2017; 31:422.</a></li><li><a class="nounderline abstract_t">Flanagan SR, Greenwald B, Wieber S. Pharmacological treatment of insomnia for individuals with brain injury. J Head Trauma Rehabil 2007; 22:67.</a></li><li><a class="nounderline abstract_t">Worthington AD, Melia Y. Rehabilitation is compromised by arousal and sleep disorders: results of a survey of rehabilitation centres. Brain Inj 2006; 20:327.</a></li><li><a class="nounderline abstract_t">Li Pi Shan RS, Ashworth NL. Comparison of lorazepam and zopiclone for insomnia in patients with stroke and brain injury: a randomized, crossover, double-blinded trial. Am J Phys Med Rehabil 2004; 83:421.</a></li><li><a class="nounderline abstract_t">Kemp S, Biswas R, Neumann V, Coughlan A. The value of melatonin for sleep disorders occurring post-head injury: a pilot RCT. Brain Inj 2004; 18:911.</a></li><li><a class="nounderline abstract_t">Grima NA, Rajaratnam SMW, Mansfield D, et al. Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial. BMC Med 2018; 16:8.</a></li><li><a class="nounderline abstract_t">Barlow KM, Esser MJ, Veidt M, Boyd R. Melatonin as a Treatment after Traumatic Brain Injury: A Systematic Review and Meta-Analysis of the Pre-Clinical and Clinical Literature. J Neurotrauma 2019; 36:523.</a></li><li><a class="nounderline abstract_t">Barlow KM, Kirk V, Brooks B, et al. Efficacy of Melatonin for Sleep Disturbance in Children with Persistent Post-Concussion Symptoms: Secondary Analysis of a Randomized Controlled Trial. J Neurotrauma 2021; 38:950.</a></li><li><a class="nounderline abstract_t">Nagtegaal JE, Kerkhof GA, Smits MG, et al. Traumatic brain injury-associated delayed sleep phase syndrome. Funct Neurol 1997; 12:345.</a></li><li><a class="nounderline abstract_t">Seda G, Sanchez-Ortuno MM, Welsh CH, et al. Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress. J Clin Sleep Med 2015; 11:11.</a></li><li><a class="nounderline abstract_t">Brock MS, Matsangas P, Creamer JL, et al. Clinical and polysomnographic features of trauma associated sleep disorder. J Clin Sleep Med 2022; 18:2775.</a></li><li><a class="nounderline abstract_t">Raskind MA, Peskind ER, Chow B, et al. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. N Engl J Med 2018; 378:507.</a></li><li><a class="nounderline abstract_t">Gottlieb DJ, Punjabi NM, Mehra R, et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med 2014; 370:2276.</a></li><li><a class="nounderline abstract_t">Giles TL, Lasserson TJ, Smith BJ, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006; :CD001106.</a></li><li><a class="nounderline abstract_t">Araghi MH, Chen YF, Jagielski A, et al. Effectiveness of lifestyle interventions on obstructive sleep apnea (OSA): systematic review and meta-analysis. Sleep 2013; 36:1553.</a></li><li><a class="nounderline abstract_t">Chirinos JA, Gurubhagavatula I, Teff K, et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med 2014; 370:2265.</a></li><li><a class="nounderline abstract_t">Castriotta RJ, Atanasov S, Wilde MC, et al. Treatment of sleep disorders after traumatic brain injury. J Clin Sleep Med 2009; 5:137.</a></li><li><a class="nounderline abstract_t">Wilde MC, Castriotta RJ, Lai JM, et al. Cognitive impairment in patients with traumatic brain injury and obstructive sleep apnea. Arch Phys Med Rehabil 2007; 88:1284.</a></li><li><a class="nounderline abstract_t">Steward KA, Silva MA, Maduri P, et al. Obstructive sleep apnea is associated with worse cognitive outcomes in acute moderate-to-severe traumatic brain injury: A TBI Model Systems study. Sleep Med 2022; 100:454.</a></li></ol></div><div id="topicVersionRevision">Topic 96439 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25110283" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Sleep and wake disturbances following traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19461363" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Traumatic brain injury and sleep disturbance: a review of current research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28329120" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Sleep-Wake Disturbances After Traumatic Brain Injury: Synthesis of Human and Animal Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22441999" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Traumatic brain injury and disturbed sleep and wakefulness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17694722" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prevalence and consequences of sleep disorders in traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16717498" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Insomnia in patients with traumatic brain injury: frequency, characteristics, and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33658328" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Traumatic Brain Injury and Incidence Risk of Sleep Disorders in Nearly 200,000 US Veterans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19147402" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Relationship among subjective sleep complaints, headaches, and mood alterations following a mild traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8551320" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11697461" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Short-term sequelae of minor head injury (6 years experience of minor head injury clinic).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26138280" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Sleep difficulties one year following mild traumatic brain injury in a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36413091" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Sleep outcomes in pediatric mild traumatic brain injury: a systematic review and meta-analysis of prevalence and contributing factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19171947" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Return of memory and sleep efficiency following moderate to severe closed head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23296143" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Prospective evaluation of the nature, course, and impact of acute sleep abnormality after traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22705246" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prevalence of sleep disturbances, disorders, and problems following traumatic brain injury: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16934524" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Subjective and objective measures of insomnia in the context of traumatic brain injury: a preliminary study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17584779" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20884672" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Sleep-wake disturbances 3 years after traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16251950" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Hypothalamic regulation of sleep and circadian rhythms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16009905" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19847903" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Loss of hypocretin (orexin) neurons with traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24337480" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Dietary therapy mitigates persistent wake deficits caused by mild traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22607167" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Controlled cortical impact traumatic brain injury acutely disrupts wakefulness and extracellular orexin dynamics as determined by intracerebral microdialysis in mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29315422" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Dietary therapy restores glutamatergic input to orexin/hypocretin neurons after traumatic brain injury in mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25363332" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Damage to histaminergic tuberomammillary neurons and other hypothalamic neurons with traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27091531" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Damage to Arousal-Promoting Brainstem Neurons with Traumatic Brain Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25587567" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Role of melatonin in traumatic brain injury and spinal cord injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20498441" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Sleep disturbance and melatonin levels following traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25477861" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Measurement of serum melatonin in intensive care unit patients: changes in traumatic brain injury, trauma, and medical conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27221043" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Circadian Melatonin Rhythm Following Traumatic Brain Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25595147" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Increased sleep need and daytime sleepiness 6 months after traumatic brain injury: a prospective controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34050005" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Location of Subcortical Microbleeds and Recovery of Consciousness After Severe Traumatic Brain Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22459784" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Sleep disturbances among soldiers with combat-related traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11689971" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Excessive daytime sleepiness in adults with brain injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17694724" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Hypersomnia following traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15575799" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Epidemiology of daytime sleepiness: definitions, symptomatology, and prevalence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15575799" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Epidemiology of daytime sleepiness: definitions, symptomatology, and prevalence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17561629" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Posttraumatic narcolepsy--two case reports and a mini review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17310860" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The epidemiology of narcolepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27164676" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Sleep-wake disorders persist 18 months after traumatic brain injury but remain underrecognized.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16230322" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Kleine-Levin syndrome: a systematic review of 186 cases in the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23837871" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Excessive sleep need following traumatic brain injury: a case-control study of 36 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8976315" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Sleep and pain complaints in symptomatic traumatic brain injury and neurologic populations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9715917" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Defining sleep disturbance after brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35033968" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Prevalence of insomnia and insomnia symptoms following mild-traumatic brain injury: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23729938" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Repetitive traumatic brain injury (or concussion) increases severity of sleep disturbance among deployed military personnel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35080600" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Trajectories of Insomnia in Adults After Traumatic Brain Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30373686" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Increased Sleep Disturbances and Pain in Veterans With Comorbid Traumatic Brain Injury and Posttraumatic Stress Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32529231" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Prevalence rates and correlates of insomnia disorder in post-9/11 veterans enrolling in VA healthcare.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23131966" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Insomnia, fatigue, and sleepiness in the first 2 years after traumatic brain injury: an NIDRR TBI model system module study</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24379082" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Rest-Activity Cycle Disturbances in the Acute Phase of Moderate to Severe Traumatic Brain Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18083618" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Polysomnographic and quantitative EEG analysis of subjects with long-term insomnia complaints associated with mild traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7010946" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Biological rhythms in man: relationship of sleep-wake, cortisol, growth hormone, and temperature during temporal isolation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32161046" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Circadian rhythm in the assessment of postconcussion insomnia: a cross-sectional observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11275462" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Long-term sleep disturbances in adolescents after minor head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17694723" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Sleep disorders in chronic traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31587047" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Posttraumatic stress disorder increases the odds of REM sleep behavior disorder and other parasomnias in Veterans with and without comorbid traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28363448" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Trauma associated sleep disorder: A parasomnia induced by trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30656131" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Trauma-Associated Sleep Disturbances: a Distinct Sleep Disorder?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25317096" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Trauma associated sleep disorder: a proposed parasomnia encompassing disruptive nocturnal behaviors, nightmares, and REM without atonia in trauma survivors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32162669" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Time to recognize trauma associated sleep disorder as a distinct parasomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32309858" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : A time to recognize trauma-related sleep disorder or a time to pause and consider?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32232880" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Post-Traumatic Stress Disorder is Associated with further Increased Parkinson's Disease Risk in Veterans with Traumatic Brain Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11245752" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Sleep apnea in adults with traumatic brain injury: a preliminary investigation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10680799" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Hypersomnia after head-neck trauma: a medicolegal dilemma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21882777" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Sleep disruptions among returning combat veterans from Iraq and Afghanistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19001250" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Is there a link between alertness and fatigue in patients with traumatic brain injury?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23681455" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Sleep disorders in US military personnel: a high rate of comorbid insomnia and obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21870901" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Axis I and II psychiatric disorders in patients with traumatic brain injury: a 12-month follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15083420" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Psychiatric challenges in the first 6 years after traumatic brain injury: cross-sequential analyses of Axis I disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12813115" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23549523" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Changes in sleep patterns following traumatic brain injury: a controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22573041" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Fatigue and sleep disturbance following traumatic brain injury--their nature, causes, and potential treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24290044" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Longitudinal relationships of insomnia, nightmares, and PTSD severity in recent combat veterans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20448312" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Posttraumatic stress symptoms in OIF/OEF service members with blast-related and non-blast-related mild TBI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24391583" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : A possible mechanism for PTSD symptoms in patients with traumatic brain injury: central autonomic network disruption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24391583" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : A possible mechanism for PTSD symptoms in patients with traumatic brain injury: central autonomic network disruption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18698069" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Prevalence of chronic pain after traumatic brain injury: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18698069" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Prevalence of chronic pain after traumatic brain injury: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21677251" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Sleep disturbance after mild traumatic brain injury: indicator of injury?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23510169" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Rapid EEG activity during sleep dominates in mild traumatic brain injury patients with acute pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23583625" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : The microstructure of sleep in primary insomnia: an overview and extension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26959664" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Sleep Features on Continuous Electroencephalography Predict Rehabilitation Outcomes After Severe Traumatic Brain Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35640250" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Sleep from acute to chronic traumatic brain injury and cognitive outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30053263" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Poor sleep is linked to impeded recovery from traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29452727" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : A systematic review and meta-analysis of sleep architecture and chronic traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36639092" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Intensive Outpatient Program Response Among Service Members With Mild Traumatic Brain Injury: Change Between Distinct Post-Concussive Symptom Subgroups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24211035" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Screening for sleep dysfunction after traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17454690" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Awareness typologies, long-term emotional adjustment and psychosocial outcomes following acquired brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18452730" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Poor sleep quality and changes in objectively recorded sleep after traumatic brain injury: a preliminary study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2748771" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11327555" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Insomnia screening in postacute traumatic brain injury: utility and validity of the Pittsburgh Sleep Quality Index.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23706309" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Self-report instruments for assessing sleep dysfunction in an adult traumatic brain injury population: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32758413" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : The relationship between depressive symptoms, somatic complaints, and concussion history with poor sleep in collegiate athletes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20334470" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Actigraphy for assessment of sleep in traumatic brain injury: case series, review of the literature and proposed criteria for use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23394102" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Actigraphic assessment of sleep disturbances following traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32125095" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Coherence Between Sleep Detection by Actigraphy and Polysomnography in a Multi-Center, Inpatient Cohort of Individuals with Traumatic Brain Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32125095" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Coherence Between Sleep Detection by Actigraphy and Polysomnography in a Multi-Center, Inpatient Cohort of Individuals with Traumatic Brain Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19464232" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18663247" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Prevalence of sleep disturbance in closed head injury patients in a rehabilitation unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24070180" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Evaluating the impact of treatment for sleep/wake disorders on recovery of cognition and communication in adults with chronic TBI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25325609" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21079179" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34743789" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34743790" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9278632" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Idiopathic hypersomnia. A series of 42 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8645441" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Successful treatment of post-traumatic narcolepsy with methylphenidate: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24213962" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Randomized controlled trial of light therapy for fatigue following traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31246878" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Blue-Enriched White Light Therapy Reduces Fatigue in Survivors of Severe Traumatic Brain Injury: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31751607" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : A randomized, double-blind, placebo-controlled trial of blue wavelength light exposure on sleep and recovery of brain structure, function, and cognition following mild traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32472836" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Daily Morning Blue Light Therapy Improves Daytime Sleepiness, Sleep Quality, and Quality of Life Following a Mild Traumatic Brain Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35421086" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Feasibility and preliminary efficacy for morning bright light therapy to improve sleep and plasma biomarkers in US Veterans with TBI. A prospective, open-label, single-arm trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25870584" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Efficacy, dosage, and duration of action of branched chain amino Acid therapy for traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35602971" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Dietary Supplementation With Branched Chain Amino Acids to Improve Sleep in Veterans With Traumatic Brain Injury: A Randomized Double-Blind Placebo-Controlled Pilot and Feasibility Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18047872" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Efficacy of cognitive-behavioral therapy for insomnia associated with traumatic brain injury: a single-case experimental design.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21386714" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Acupuncture for treatment of insomnia in patients with traumatic brain injury: a pilot intervention study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30549498" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Acupuncture for Treatment of Persistent Disturbed Sleep: A Randomized Clinical Trial in Veterans With Mild Traumatic Brain Injury and Posttraumatic Stress Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31927422" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Non-pharmacological treatment for insomnia following acquired brain injury: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28326852" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Sleep outcomes following sleep-hygiene-related interventions for individuals with traumatic brain injury: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17235234" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Pharmacological treatment of insomnia for individuals with brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16537274" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Rehabilitation is compromised by arousal and sleep disorders: results of a survey of rehabilitation centres.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15166685" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Comparison of lorazepam and zopiclone for insomnia in patients with stroke and brain injury: a randomized, crossover, double-blinded trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15223743" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : The value of melatonin for sleep disorders occurring post-head injury: a pilot RCT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29347988" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29901413" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Melatonin as a Treatment after Traumatic Brain Injury: A Systematic Review and Meta-Analysis of the Pre-Clinical and Clinical Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32988292" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Efficacy of Melatonin for Sleep Disturbance in Children with Persistent Post-Concussion Symptoms: Secondary Analysis of a Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9503198" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Traumatic brain injury-associated delayed sleep phase syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25325592" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35962771" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Clinical and polysomnographic features of trauma associated sleep disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29414272" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24918372" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : CPAP versus oxygen in obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16437429" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Continuous positive airways pressure for obstructive sleep apnoea in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24082315" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Effectiveness of lifestyle interventions on obstructive sleep apnea (OSA): systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24918371" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : CPAP, weight loss, or both for obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19968047" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Treatment of sleep disorders after traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17908570" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Cognitive impairment in patients with traumatic brain injury and obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36252414" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Obstructive sleep apnea is associated with worse cognitive outcomes in acute moderate-to-severe traumatic brain injury: A TBI Model Systems study.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
